Diversion within healthcare settings
Addiction to prescription narcotics has reached epidemic proportions and is a major driver of drug diversion within healthcare settings. Diversion can cause significant financial loss and potentially impact care to patients and staff safety. In addition, accrediting and regulating agencies require pharmacies to maintain the accountability, security and control of controlled substances, and promptly identify any movement or diversion. Due to the magnitude of these issues, BD continues to work with our customers and thought leaders to deliver meaningful tools and references to help implement policies and procedures.
Through our scale and unmatched expertise, BD is uniquely positioned to partner with customers to develop a comprehensive diversion-detection program comprised of policies, tools, technologies and analytics spanning the medication-use continuum. Our core solutions provide a comprehensive, closed-loop approach to controlled-substance medication management.
Educational Resources
BD Best Practices
* This document is available via our Customer Portal. Please login in order to download.
Testimonials
"RxAuditor gives me the ability to analyze data in a quick and comprehensive manner. It goes beyond ‘transactions per month' to assess ‘transactions per shift', the percent of ADM transactions involving controlled substances, waste pairings, and much more. I greatly value having access to these data as a part of our diversion prevention and detection program."
Brian O'Neal, PharmD, MS, FASHP
Co-Author and Reviewer of ASHP Guidelines on Preventing Diversion of Controlled Substances
Senior Director of Pharmacy and Biomedical Engineering
Children's Mercy Kansas City
"RxAuditor helps me at each step of the ASHP's compliance and monitoring cycle. Medacist's Ten Step RxReview process helps me zero in on areas of concern. The process is concise and I can use the information to identify trends and investigate. The TriageRx and TrendRx indicators are easy to explain to nurse managers and administration. Monitoring would take a lot more time without it."
Steven Burke, R.Ph.
Director of Pharmacy
Bristol Hospital
"We have had several diversion situations identified that we would not have known about or caught without the use of the RxAuditor report. Just this September we identified a nurse that had been diverting from the hospital for 4 years. She started showing up on our RxAuditor report for Dilaudid (hydromorphone) for the last year. There were several "educational" conversations that took place and nursing leadership medication administration observations. The trouble with our situation was she was a very high performing nurse that received compliments from both staff and patients. She was "the last person you would suspect to be diverting." The report finally told the story. This finally hit home to the nursing leadership and she was brought in for a drug screen. She openly shared what she had been doing and really seemed to be relieved that this was ending."
Stacy Boatright, Rph
Director of Pharmacy
Women's & Children's Hospital
BD is a proud sponsor of:
BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.